NL
NL · NL · NL-06123b0f3387
Ultomiris 300 mg/3 ml concentraat voor oplossing voor infusie
ATC L04AJ02
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerAlexion Europe S.A.S.
CountryNL (NL)
ATC codeL04AJ02
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/19/1371
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ultomiris-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Ravulizumab",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp123410",
"excipients": [
"ARGININE, (L-)",
"DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"POLYSORBAAT 80 (E 433)",
"SACCHAROSE",
"WATER VOOR INJECTIE"
],
"substances": [
"RAVULIZUMAB"
],
"leaflet_url": null,
"authorised_at": "2019/07/02",
"procedure_number": "EMEA/H/C/004954",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/19/1371",
"additional_monitoring": "N"
}Related drugs
Other records sharing ATC code L04AJ02.
Access this data programmatically
Query Ultomiris 300 mg/3 ml concentraat voor oplossing voor infusie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.